Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
$430K Sell
10,989
-1,618
-13% -$64.2K 0.03% 789
2015
Q2
$480K Sell
12,607
-1,196
-9% -$41.9K 0.03% 765
2015
Q1
$456K Sell
13,803
-1,024
-7% -$31.4K 0.03% 786
2014
Q4
$396K Sell
14,827
-2,385
-14% -$61.6K 0.03% 834
2014
Q3
$419K Buy
17,212
+976
+6% +$24.6K 0.03% 729
2014
Q2
$412K Sell
16,236
-908
-5% -$21.2K 0.03% 755
2014
Q1
$369K Buy
17,144
+2,606
+18% +$56.2K 0.03% 757
2013
Q4
$325K Buy
14,538
+1,641
+13% +$36.2K 0.03% 800
2013
Q3
$266K Buy
12,897
+1,670
+15% +$35.5K 0.03% 799
2013
Q2
$217K Buy
+11,227
New +$235K 0.02% 831

Other funds holding HOLX

OFI Advisors's HOLX Position: Q3 2015 in Review

OFI Advisors reduced its Hologic (HOLX) stake by 13% in Q3 2015, selling an estimated $64.2K and leaving 10,989 shares worth $430K. The position accounts for 0.03% of the portfolio, ranked #789.

OFI Advisors first reported a position in HOLX in Q2 2013 and has held it in 10 quarters since. The position peaked at $480K in Q2 2015. 436 funds tracked by Wall St. Rank hold HOLX as of Q3 2015.

  • OFI Advisors held 10,989 shares of Hologic worth $430K as of Q3 2015.
  • OFI Advisors sold 1,618 Hologic shares in Q3 2015, an estimated $64.2K.
  • Hologic made up 0.03% of OFI Advisors's portfolio in Q3 2015, its #789 holding.
  • OFI Advisors first reported a position in Hologic in Q2 2013 and has held it in 10 quarters since.
  • OFI Advisors's Hologic position peaked at $480K in Q2 2015.
  • 436 funds tracked by Wall St. Rank held Hologic as of Q3 2015.

Based on OFI Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.